Share Prices & Company Research

Stockbroking

Immunodiagnostic Systems Holdings

Current Price 210.00p Bid 200.00p Ask 210.00p Change 0.00%
Last Updated: 21/09/2019 07:43. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Immunodiagnostic Systems Holdings plc (IDS) is a specialist in-vitro diagnostic solution provider to the clinical laboratory market and producer of manual and automated diagnostic testing kits and instruments for the clinical market.

Financial Highlights Year Ended 31/03/2019

Turnover
£38.51m
Operating Profit
£0.43m
Dividend Yield
0.34
Dividend Per Share
0.70
Dividend Cover
3.86
P/E Ratio
75.93

Key Personnel

Jaap Stuut
Chief Executive Officer
Paul James Martin
Chief Financial Officer
Dr Burkhard Wittek
Non-Executive Chairman
Klaus Peter Kaspar
Non-Executive Director
Peter John Williamson
Non-Executive Director

Stock Details

EPIC
IDH
ISIN
GB00B01YZ052
Shares in Issue
28,784,097
Market cap
£59.01m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
205.00p
Bid Price
200.00p
Ask Price
210.00p
Volume
5509
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
205.00p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
236.00p
52 Week Low
167.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Immunodiagnostic Systems Holdings Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Tangible Assets
6.9
7.5
Intangible Assets & Goodwill
11.2
11.0
Investments & Other Non-Current Assets
0.4
0.7
Total Non-Current Assets
18.4
19.2
Inventory
7.8
8.4
Trade & Receivables
9.0
8.4
Cash & Receivables
27.7
28.5
Other Current Assets & Assets Held for Resale
3.1
3.1
Total Assets
65.9
67.5

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Short Term Liabilities
7.3
7.3
Long Term Liabilities
3.3
3.4
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
10.6
10.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Net Assets
55.3
56.9

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Share Capital
0.6
0.6
Minority Interests
0.0
0.0
Retained Earnings
17.7
18.8
Share Premium Account
32.4
32.4
Other Equity
4.7
5.2
Total Equity
55.3
56.9

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Cashflow from Operating Activities
5.8
2.5
Cashflow Before Financing
1.4
-1.4
Increase / Decrease in Cash
-0.7
-1.4

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Turnover
38.5
38.0
Cost of Sales
21.8
19.9
Gross Profit
16.7
18.0
Operating Profit
0.4
1.0
Pre-Tax Profit
0.8
0.9
Profit / Loss for the Year
0.8
1.2

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H2 Dividend
18 Jul 2019
15 Aug 2019
H2 Dividend
19 Jul 2018
17 Aug 2018
H2 Dividend
20 Jul 2017
18 Aug 2017
H2 Dividend
21 Jul 2016
19 Aug 2016
H2 Dividend
23 Jul 2015
21 Aug 2015
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.